Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities
Net income	$ 107,492	$ 1,044,031
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	536,200	260,717
Amortization of deferred financing costs and debt discount	11,978	13,123
Straight-line rent revenue and other	(174,202)	(214,435)
Stock / (Unit)-based compensation expense	29,719	33,001
Gain on sale of real estate	(209)	(536,788)
Real estate and other impairment charges (recovery)	93,288	(14,575)
Straight-line rent and other write-off	150,576	35,259
Debt refinancing and unutilized financing (benefit) costs	(46)	9,452
Tax rate changes and other	(164,535)	6,901
Non-cash revenue from debt and equity securities received	(81,706)
Other adjustments	(27,500)	(2,136)
Changes in:
Interest and rent receivables	(100,384)	(68,929)
Other assets	(6,701)	(7,551)
Accounts payable and accrued expenses	(6,279)	8,030
Deferred revenue	2,677	(8,185)
Net cash provided by operating activities	370,368	557,915
Investing activities
Cash paid for acquisitions and other related investments	(235,187)	(972,243)
Net proceeds from sale of real estate	589,420	2,185,574
Principal received on loans receivable	499,549	52,317
Investment in loans receivable	(220,223)	(179,542)
Construction in progress and other	(80,708)	(97,783)
Proceeds from return of equity investments	12,430	14,295
Capital additions and other investments, net	(217,940)	(144,307)
Net cash provided by investing activities	347,341	858,311
Financing activities
Payments of term debt	(533,864)	(869,606)
Revolving credit facility, net	426,515	(64,055)
Dividends paid	(524,155)	(524,536)
Lease deposits and other obligations to tenants	7,752	(2,591)
Stock vesting - satisfaction of tax withholdings	(6,090)	(29,457)
Debt refinancing, deferred financing costs, and other financing activities	12,243	(53,444)
Net cash used for financing activities	(617,599)	(1,543,689)
Increase (decrease) in cash, cash equivalents, and restricted cash for period	100,110	(127,463)
Effect of exchange rate changes	4,238	(29,739)
Cash, cash equivalents, and restricted cash at beginning of period	241,538	461,882
Cash, cash equivalents, and restricted cash at end of period	345,886	304,680
Interest paid	322,006	285,417
Supplemental schedule of non-cash investing activities:
Debt and equity securities received for certain obligations, real estate, and revenue	804,520
Certain obligations and receivables satisfied and real estate sold	722,814
Supplemental schedule of non-cash financing activities:
Dividends declared, unpaid	90,467	173,999
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	235,668	459,227
Restricted cash, included in Other assets at beginning of period	$ 5,870	$ 2,655
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 241,538	$ 461,882
Cash and cash equivalents at end of period	340,058	299,171
Restricted cash, included in Other assets at end of period	$ 5,828	$ 5,509
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 345,886	$ 304,680
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	107,492	1,044,031
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	536,200	260,717
Amortization of deferred financing costs and debt discount	11,978	13,123
Straight-line rent revenue and other	(174,202)	(214,435)
Stock / (Unit)-based compensation expense	29,719	33,001
Gain on sale of real estate	(209)	(536,788)
Real estate and other impairment charges (recovery)	93,288	(14,575)
Straight-line rent and other write-off	150,576	35,259
Debt refinancing and unutilized financing (benefit) costs	(46)	9,452
Tax rate changes and other	(164,535)	6,901
Non-cash revenue from debt and equity securities received	(81,706)
Other adjustments	(27,500)	(2,136)
Changes in:
Interest and rent receivables	(100,384)	(68,929)
Other assets	(6,701)	(7,551)
Accounts payable and accrued expenses	(6,279)	8,030
Deferred revenue	2,677	(8,185)
Net cash provided by operating activities	370,368	557,915
Investing activities
Cash paid for acquisitions and other related investments	(235,187)	(972,243)
Net proceeds from sale of real estate	589,420	2,185,574
Principal received on loans receivable	499,549	52,317
Investment in loans receivable	(220,223)	(179,542)
Construction in progress and other	(80,708)	(97,783)
Proceeds from return of equity investments	12,430	14,295
Capital additions and other investments, net	(217,940)	(144,307)
Net cash provided by investing activities	347,341	858,311
Financing activities
Payments of term debt	(533,864)	(869,606)
Revolving credit facility, net	426,515	(64,055)
Dividends paid	(524,155)	(524,536)
Lease deposits and other obligations to tenants	7,752	(2,591)
Stock vesting - satisfaction of tax withholdings	(6,090)	(29,457)
Debt refinancing, deferred financing costs, and other financing activities	12,243	(53,444)
Net cash used for financing activities	(617,599)	(1,543,689)
Increase (decrease) in cash, cash equivalents, and restricted cash for period	100,110	(127,463)
Effect of exchange rate changes	4,238	(29,739)
Cash, cash equivalents, and restricted cash at beginning of period	241,538	461,882
Cash, cash equivalents, and restricted cash at end of period	345,886	304,680
Interest paid	322,006	285,417
Supplemental schedule of non-cash investing activities:
Debt and equity securities received for certain obligations, real estate, and revenue	804,520
Certain obligations and receivables satisfied and real estate sold	722,814
Supplemental schedule of non-cash financing activities:
Dividends declared, unpaid	90,467	173,999
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	235,668	459,227
Restricted cash, included in Other assets at beginning of period	$ 5,870	$ 2,655
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 241,538	$ 461,882
Cash and cash equivalents at end of period	340,058	299,171
Restricted cash, included in Other assets at end of period	$ 5,828	$ 5,509
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 345,886	$ 304,680